{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:25:35Z","timestamp":1767140735377,"version":"build-2238731810"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T00:00:00Z","timestamp":1620604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T00:00:00Z","timestamp":1620604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s00403-021-02232-z","type":"journal-article","created":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T15:03:46Z","timestamp":1620659026000},"page":"369-378","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Sentinel node tumor burden in cutaneous melanoma. Survival with competing risk analysis and influence in relapses and non-sentinel node status: retrospective cohort study with long follow-up in a Spanish population"],"prefix":"10.1007","volume":"314","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5261-2031","authenticated-orcid":false,"given":"Leire","family":"Loidi-Pascual","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juli\u00e1n","family":"Librero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"C\u00f3rdoba-Iturriagagoitia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Guarch-Troyas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Montes-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yerani","family":"Ruiz de Azua-Ciria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imanol","family":"Arozarena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Go\u00f1i-Giron\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Yanguas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,10]]},"reference":[{"key":"2232_CR1","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa1310460","volume":"370","author":"DL Morton","year":"2014","unstructured":"Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Nieweg OE, Roses DF et al (2014) Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med 370:599\u2013609","journal-title":"N Engl J Med"},{"issue":"3 Suppl","key":"2232_CR2","doi-asserted-by":"publisher","first-page":"162S","DOI":"10.1245\/ASO.2004.12.920","volume":"11","author":"H Starz","year":"2004","unstructured":"Starz H, Siedlecki K, Balda B-R (2004) Sentinel lymphonodectomy and s-classification: a successful strategy for better prediction and improvement of outcome of melanoma. Ann Surg Oncol 11(3 Suppl):162S-S168","journal-title":"Ann Surg Oncol"},{"key":"2232_CR3","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1309\/TDWJTR15TDM1TG7Q","volume":"122","author":"RA Scolyer","year":"2004","unstructured":"Scolyer RA, Li L-XL, McCarthy SW, Shaw HM, Stretch JR, Sharma R et al (2004) Micromorphometric features of positive sentinel lymph nodes predict involvement of nonsentinel nodes in patients with melanoma. Am J Clin Pathol 122:532\u2013539","journal-title":"Am J Clin Pathol"},{"key":"2232_CR4","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1200\/JCO.2004.12.177","volume":"22","author":"DJ Dewar","year":"2004","unstructured":"Dewar DJ, Newell B, Green MA, Topping AP, Powell BWEM, Cook MG (2004) The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J Clin Oncol 22:3345\u20133349","journal-title":"J Clin Oncol"},{"key":"2232_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jamcollsurg.2005.03.029","volume":"201","author":"MS Sabel","year":"2005","unstructured":"Sabel MS, Griffith K, Sondak VK, Lowe L, Schwartz JL, Cimmino VM et al (2005) Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma. J Am Coll Surg 201:37\u201347","journal-title":"J Am Coll Surg"},{"key":"2232_CR6","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1093\/annonc\/mdl176","volume":"17","author":"ACJ van Akkooi","year":"2006","unstructured":"van Akkooi ACJ, de Wilt JHW, Verhoef C, Schmitz PIM, van Geel AN, Eggermont AMM et al (2006) Clinical relevance of melanoma micrometastases (< 0.1 mm) in sentinel nodes: are these nodes to be considered negative? Ann Oncol 17:1578\u20131585","journal-title":"Ann Oncol"},{"key":"2232_CR7","doi-asserted-by":"publisher","first-page":"4296","DOI":"10.1200\/JCO.2007.15.4179","volume":"26","author":"JE Gershenwald","year":"2008","unstructured":"Gershenwald JE, Andtbacka RHI, Prieto VG, Johnson MM, Diwan AH, Lee JE et al (2008) Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma. J Clin Oncol 26:4296\u20134303","journal-title":"J Clin Oncol"},{"key":"2232_CR8","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1245\/s10434-011-2095-3","volume":"19","author":"FL Baehner","year":"2012","unstructured":"Baehner FL, Li R, Jenkins T, Hwang J, Kashani-Sabet M, Allen RE et al (2012) The impact of primary melanoma thickness and microscopic tumor burden in sentinel lymph nodes on melanoma patient survival. Ann Surg Oncol 19:1034\u20131042","journal-title":"Ann Surg Oncol"},{"key":"2232_CR9","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1200\/JCO.2010.31.6760","volume":"29","author":"APT van der Ploeg","year":"2011","unstructured":"van der Ploeg APT, van Akkooi ACJ, Rutkowski P, Nowecki ZI, Michej W, Mitra A et al (2011) Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria. J Clin Oncol 29:2206\u20132214","journal-title":"J Clin Oncol"},{"key":"2232_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ejca.2013.08.023","volume":"50","author":"APT van der Ploeg","year":"2014","unstructured":"van der Ploeg APT, van Akkooi ACJ, Haydu LE, Scolyer RA, Murali R, Verhoef C et al (2014) The prognostic significance of sentinel node tumour burden in melanoma patients: an international, multicenter study of 1539 sentinel node-positive melanoma patients. Eur J Cancer 50:111\u2013120","journal-title":"Eur J Cancer"},{"key":"2232_CR11","first-page":"301","volume":"35","author":"C Kim","year":"2015","unstructured":"Kim C, Economou S, Amatruda TT, Martin JC, Dudek AZ (2015) Prognostic significance of microscopic tumor burden in sentinel lymph node in patients with cutaneous melanoma. Anticancer Res 35:301\u2013309","journal-title":"Anticancer Res"},{"key":"2232_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.amjsurg.2015.05.016","volume":"211","author":"A Kibrit\u00e9","year":"2016","unstructured":"Kibrit\u00e9 A, Milot H, Douville P, Gagn\u00e9 \u00c9J, Labont\u00e9 S, Friede J et al (2016) Predictive factors for sentinel lymph nodes and non-sentinel lymph nodes metastatic involvement: a database study of 1,041 melanoma patients. Am J Surg 211:89\u201394","journal-title":"Am J Surg"},{"key":"2232_CR13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/CMR.0000000000000481","volume":"29","author":"L Borgognoni","year":"2019","unstructured":"Borgognoni L, Bellucci F, Urso C, Manneschi G, Gerlini G, Brandani P et al (2019) Enhancing the prognostic role of melanoma sentinel lymph nodes through microscopic tumour burden characterization: clinical usefulness in patients who do not undergo complete lymph node dissection. Melanoma Res 29:163\u2013171","journal-title":"Melanoma Res"},{"key":"2232_CR14","doi-asserted-by":"publisher","first-page":"7585","DOI":"10.1158\/1078-0432.CCR-19-1194","volume":"25","author":"K Namikawa","year":"2019","unstructured":"Namikawa K, Aung PP, Milton DR, Tetzlaff MT, Torres-Cabala CA, Curry JL et al (2019) Correlation of tumor burden in sentinel lymph nodes with tumor burden in nonsentinel lymph nodes and survival in cutaneous melanoma. Clin Cancer Res 25:7585\u20137593","journal-title":"Clin Cancer Res"},{"key":"2232_CR15","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/CMR.0000000000000276","volume":"26","author":"JR Hoag","year":"2016","unstructured":"Hoag JR, Hegde U, Zweifler R, Berwick M, Swede H (2016) Competing risks survival of older patients with metastatic cutaneous melanoma: a SEER population-based study. Melanoma Res 26:505\u2013512","journal-title":"Melanoma Res"},{"key":"2232_CR16","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1186\/s12885-016-2438-3","volume":"16","author":"W Shen","year":"2016","unstructured":"Shen W, Sakamoto N, Yang L (2016) Melanoma-specific mortality and competing mortality in patients with non-metastatic malignant melanoma: a population-based analysis. BMC Cancer 16:413","journal-title":"BMC Cancer"},{"key":"2232_CR17","unstructured":"R: A language and environment for statistical computing. [Internet]. Vienna, Austria: R Foundation for Statistical Computing; 2013. http:\/\/www.R-project.org\/"},{"key":"2232_CR18","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S1470-2045(16)00141-8","volume":"17","author":"U Leiter","year":"2016","unstructured":"Leiter U, Stadler R, Mauch C, Hohenberger W, Brockmeyer N, Berking C et al (2016) Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial. Lancet Oncol 17:757\u2013767","journal-title":"Lancet Oncol"},{"key":"2232_CR19","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","volume":"376","author":"MB Faries","year":"2017","unstructured":"Faries MB, Thompson JF, Cochran AJ, Andtbacka RH, Mozzillo N, Zager JS et al (2017) Completion dissection or observation for sentinel-node metastasis in melanoma. N Engl J Med 376:2211\u20132222","journal-title":"N Engl J Med"},{"key":"2232_CR20","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1200\/JCO.2017.75.7724","volume":"36","author":"SL Wong","year":"2018","unstructured":"Wong SL, Faries MB, Kennedy EB, Agarwala SS, Akhurst TJ, Ariyan C et al (2018) Sentinel lymph node biopsy and management of regional lymph nodes in melanoma: American Society of Clinical Oncology and Society of Surgical Oncology clinical practice guideline update. J Clin Oncol 36:399\u2013413","journal-title":"J Clin Oncol"},{"key":"2232_CR21","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1016\/j.ejca.2009.08.015","volume":"45","author":"ACJ van Akkooi","year":"2009","unstructured":"van Akkooi ACJ, Spatz A (2009) Expert opinion in melanoma: The sentinel node; EORTC Melanoma Group recommendations on practical methodology of the measurement of the microanatomic location of metastases and metastatic tumour burden. Eur J Cancer 45:2736\u20132742","journal-title":"Eur J Cancer"},{"key":"2232_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejca.2019.03.010","volume":"114","author":"MG Cook","year":"2019","unstructured":"Cook MG, Massi D, Szumera-Cie\u0107kiewicz A, Van den Oord J, Blokx W, van Kempen LC et al (2019) An updated European Organisation for Research and Treatment of Cancer (EORTC) protocol for pathological evaluation of sentinel lymph nodes for melanoma. Eur J Cancer 114:1\u20137","journal-title":"Eur J Cancer"},{"key":"2232_CR23","unstructured":"cp-skin-melanoma-17protocol-4010.pdf [Internet]. [cited 17 July 2020]. https:\/\/documents.cap.org\/protocols\/cp-skin-melanoma-17protocol-4010.pdf"},{"key":"2232_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s12094-017-1768-1","volume":"20","author":"A Berrocal","year":"2018","unstructured":"Berrocal A, Arance A, Castellon VE, de la Cruz L, Espinosa E, Cao MG et al (2018) SEOM clinical guideline for the management of malignant melanoma (2017). Clin Transl Oncol 20:69\u201374","journal-title":"Clin Transl Oncol"},{"key":"2232_CR25","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jaad.2018.08.055","volume":"80","author":"SM Swetter","year":"2019","unstructured":"Swetter SM, Tsao H, Bichakjian CK, Curiel-Lewandrowski C, Elder DE, Gershenwald J (2019) Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol 80:208\u2013250","journal-title":"J Am Acad Dermatol"},{"key":"2232_CR26","unstructured":"Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, et al., editors. AJCC Cancer Staging Manual [Internet]. 8th ed. Springer International Publishing; 2017 [cited 2 december 2018]. www.springer.com\/us\/book\/9783319406176"},{"key":"2232_CR27","unstructured":"Cutaneous_melanoma.pdf [Internet]. [cited 11 august 2020]. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cutaneous_melanoma.pdf"},{"key":"2232_CR28","doi-asserted-by":"publisher","first-page":"325","DOI":"10.21037\/atm.2018.07.38","volume":"6","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Cortese G, Combescure C, Marshall R, Lee M, Lim HJ et al (2018) Overview of model validation for survival regression model with competing risks using melanoma study data. Ann Transl Med 6:325","journal-title":"Ann Transl Med"},{"key":"2232_CR29","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/01.pas.0000152134.36030.b7","volume":"29","author":"K Spanknebel","year":"2005","unstructured":"Spanknebel K, Coit DG, Bieligk SC, Gonen M, Rosai J, Klimstra DS (2005) Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis. Am J Surg Pathol 29:305\u2013317","journal-title":"Am J Surg Pathol"}],"updated-by":[{"DOI":"10.1007\/s00403-021-02302-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T00:00:00Z","timestamp":1637625600000}}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-021-02232-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-021-02232-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-021-02232-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T09:13:58Z","timestamp":1649668438000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-021-02232-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,10]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["2232"],"URL":"https:\/\/doi.org\/10.1007\/s00403-021-02232-z","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,10]]},"assertion":[{"value":"2 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2021","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00403-021-02302-2","URL":"https:\/\/doi.org\/10.1007\/s00403-021-02302-2","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/competing interests"}},{"value":"Ethical approval was obtained by the local institution\u00b4s human research committee (Pamplona, Spain). This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and publication"}}]}}